200 related articles for article (PubMed ID: 35942669)
1. Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome.
Ingrosso MR; Ianiro G; Nee J; Lembo AJ; Moayyedi P; Black CJ; Ford AC
Aliment Pharmacol Ther; 2022 Sep; 56(6):932-941. PubMed ID: 35942669
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.
Black CJ; Yuan Y; Selinger CP; Camilleri M; Quigley EMM; Moayyedi P; Ford AC
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):117-131. PubMed ID: 31859183
[TBL] [Abstract][Full Text] [Related]
3. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis.
Khanna R; MacDonald JK; Levesque BG
J Clin Gastroenterol; 2014 Jul; 48(6):505-12. PubMed ID: 24100754
[TBL] [Abstract][Full Text] [Related]
4. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
Ruepert L; Quartero AO; de Wit NJ; van der Heijden GJ; Rubin G; Muris JW
Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD003460. PubMed ID: 21833945
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome.
Goodoory VC; Tuteja AK; Black CJ; Ford AC
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):243-251.e5. PubMed ID: 36858143
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
Weerts ZZRM; Masclee AAM; Witteman BJM; Clemens CHM; Winkens B; Brouwers JRBJ; Frijlink HW; Muris JWM; De Wit NJ; Essers BAB; Tack J; Snijkers JTW; Bours AMH; de Ruiter-van der Ploeg AS; Jonkers DMAE; Keszthelyi D
Gastroenterology; 2020 Jan; 158(1):123-136. PubMed ID: 31470006
[TBL] [Abstract][Full Text] [Related]
7. A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome.
Weerts ZZRM; Essers BAB; Jonkers DMAE; Willems JIA; Janssen DJPA; Witteman BJM; Clemens CHM; Westendorp A; Masclee AAM; Keszthelyi D
United European Gastroenterol J; 2021 Nov; 9(9):997-1006. PubMed ID: 34468079
[TBL] [Abstract][Full Text] [Related]
8. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data.
Alammar N; Wang L; Saberi B; Nanavati J; Holtmann G; Shinohara RT; Mullin GE
BMC Complement Altern Med; 2019 Jan; 19(1):21. PubMed ID: 30654773
[TBL] [Abstract][Full Text] [Related]
9. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.
Ford AC; Talley NJ; Spiegel BM; Foxx-Orenstein AE; Schiller L; Quigley EM; Moayyedi P
BMJ; 2008 Nov; 337():a2313. PubMed ID: 19008265
[TBL] [Abstract][Full Text] [Related]
10. Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial.
Nee J; Ballou S; Kelley JM; Kaptchuk TJ; Hirsch W; Katon J; Cheng V; Rangan V; Lembo A; Iturrino J
Am J Gastroenterol; 2021 Nov; 116(11):2279-2285. PubMed ID: 34319275
[TBL] [Abstract][Full Text] [Related]
11. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
Quartero AO; Meineche-Schmidt V; Muris J; Rubin G; de Wit N
Cochrane Database Syst Rev; 2005 Apr; (2):CD003460. PubMed ID: 15846668
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Peppermint oil in diarrhea predominant IBS - a double blind randomized placebo - controlled study.
Alam MS; Roy PK; Miah AR; Mollick SH; Khan MR; Mahmud MC; Khatun S
Mymensingh Med J; 2013 Jan; 22(1):27-30. PubMed ID: 23416804
[TBL] [Abstract][Full Text] [Related]
13. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders.
Chumpitazi BP; Kearns GL; Shulman RJ
Aliment Pharmacol Ther; 2018 Mar; 47(6):738-752. PubMed ID: 29372567
[TBL] [Abstract][Full Text] [Related]
14. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
Videlock EJ; Cheng V; Cremonini F
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis.
Black CJ; Staudacher HM; Ford AC
Gut; 2022 Jun; 71(6):1117-1126. PubMed ID: 34376515
[TBL] [Abstract][Full Text] [Related]
16. A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms.
Cash BD; Epstein MS; Shah SM
Dig Dis Sci; 2016 Feb; 61(2):560-71. PubMed ID: 26319955
[TBL] [Abstract][Full Text] [Related]
17. Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Hawrelak JA; Wohlmuth H; Pattinson M; Myers SP; Goldenberg JZ; Harnett J; Cooley K; Van De Venter C; Reid R; Whitten DL
Complement Ther Med; 2020 Jan; 48():102233. PubMed ID: 31987249
[TBL] [Abstract][Full Text] [Related]
18. Homeopathy for treatment of irritable bowel syndrome.
Peckham EJ; Cooper K; Roberts ER; Agrawal A; Brabyn S; Tew G
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD009710. PubMed ID: 31483486
[TBL] [Abstract][Full Text] [Related]
19. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis.
Pittler MH; Ernst E
Am J Gastroenterol; 1998 Jul; 93(7):1131-5. PubMed ID: 9672344
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
Zheng Y; Yu T; Tang Y; Xiong W; Shen X; Jiang L; Lin L
PLoS One; 2017; 12(3):e0172846. PubMed ID: 28291778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
